44.97
Bruker Corp stock is traded at $44.97, with a volume of 1.95M.
It is up +0.02% in the last 24 hours and down -12.08% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
See More
Previous Close:
$44.96
Open:
$44.71
24h Volume:
1.95M
Relative Volume:
1.25
Market Cap:
$6.81B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
21.62
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
-6.70%
1M Performance:
-12.08%
6M Performance:
-31.51%
1Y Performance:
-51.44%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
44.97 | 6.81B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-19-24 | Initiated | Guggenheim | Buy |
Dec-10-24 | Initiated | UBS | Neutral |
Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
Oct-15-24 | Initiated | Barclays | Overweight |
Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jun-03-24 | Resumed | Jefferies | Buy |
Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Oct-21-22 | Initiated | UBS | Buy |
Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Market Perform |
Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Dec-02-20 | Initiated | Goldman | Sell |
Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Hold |
Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
Jun-24-19 | Reiterated | Needham | Strong Buy |
Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
May-30-19 | Initiated | Wolfe Research | Peer Perform |
May-06-19 | Reiterated | Needham | Strong Buy |
May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
May-03-19 | Upgrade | UBS | Sell → Neutral |
Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
Feb-12-19 | Reiterated | BTIG Research | Buy |
Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
FY2027 Earnings Estimate for Bruker Issued By Zacks Research - Defense World
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Bruker at Leerink Conference: Navigating Challenges and Opportunities - Investing.com
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $45.13 amid market challenges - Investing.com Australia
Bruker Corp’s chief accounting officer buys $23,697 in stock - Investing.com India
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds - Investing.com
US Bancorp DE Has $694,000 Stock Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Proficio Capital Partners LLC Invests $608,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex
Zacks Research Predicts Bruker’s Q4 Earnings (NASDAQ:BRKR) - Defense World
Bruker Corp. to Host Earnings Call - ACCESS Newswire
Bruker at TD Cowen Conference: Strategic Growth in Healthcare - Investing.com
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM - Yahoo Finance
Bank of New York Mellon Corp Grows Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Is Bruker Corporation (BRKR) the Best Medical Technology Stock to Buy According to Analysts? - Yahoo Finance
BRUKER CORP SEC 10-K Report - TradingView
Truist Financial Corp Invests $910,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker launches advanced 3D X-ray microscope - Investing.com
Could This New X-Ray Technology Transform Scientific Research? Bruker's X4 POSEIDON Promises 10X Better Resolution - StockTitan
Bruker stock hits 52-week low at $48.04 amid market challenges - Investing.com
Bruker Corporation (BRKR) is on Detractors’ list of The London Company SMID Cap Strategy - Yahoo Finance
What Makes Bruker Corporation (BRKR) a Lucrative Investment? - Yahoo Canada Finance
User - Financial Content
There May Be Reason For Hope In Bruker's (NASDAQ:BRKR) Disappointing Earnings - Yahoo Finance
Bruker announces advances in proteomics technology - Investing.com
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO – Company AnnouncementFT.com - Financial Times
BRKRBruker Corp Latest Stock News & Market Updates - StockTitan
Bruker Corporation appoints new board member By Investing.com - Investing.com South Africa
Bruker Corporation appoints new board member - Investing.com
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025 - Quantisnow
Bruker Appoints Laura Francis to its Board of Directors - Yahoo Finance
Bruker Announces Quarterly Dividend - Yahoo Finance
Frank Laukien Buys Handful Of Shares In Bruker - Yahoo Canada Finance
Four Major Healthcare Conferences: Where Bruker Will Share Its 2025 Vision - StockTitan
Bruker Corporation to Present at Upcoming Investor Conferences - Yahoo Finance
Bruker corp CEO Frank Laukien buys $1.02m in company stock By Investing.com - Investing.com South Africa
Bruker corp CEO Frank Laukien buys $1.02m in company stock - Investing.com Nigeria
Allspring Global Investments Holdings LLC Increases Stake in Bruker Co. (NASDAQ:BRKR) - Defense World
Equities Analysts Set Expectations for Bruker Q1 Earnings - MarketBeat
Bruker (NASDAQ:BRKR) Issues FY 2025 Earnings Guidance - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Q4 2024 Earnings Call Transcript - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Bruker Co. (NASDAQ:BRKR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bruker Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
FY2025 Earnings Estimate for Bruker Issued By Zacks Research - MarketBeat
Bruker reports Q4 earnings beat, issues in-line 2025 guidance - MSN
Bruker (NASDAQ:BRKR) Announces Quarterly Earnings Results - MarketBeat
Glycomics Market Size Expected to Reach USD 8.66 Bn by 2034 - GlobeNewswire Inc.
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):